-
Podcast – Biotech 2050 interviews Mammoth Co-Founder and CEO Trevor Martin
Learn More -
Why is the liver a popular target for therapeutic genome editing?
Learn More -
Knocking out, writing, and modulating DNA with CRISPR
Learn More -
Using CRISPR to overcome the challenges of in vivo genome editing
Learn More -
Cell therapies and ex vivo genome editing
Learn More -
A broad overview of CRISPR delivery methods
Learn More -
Important factors to consider in CRISPR delivery
Learn More -
Cas9 Immunity
Learn More -
Expanding the possibilities of CRISPR genome editing with Cas14 and CasΦ
Learn More -